Skip to main content
Retour
Watch Compare

Zentalis Pharmaceuticals, Inc.

Qualité des données : 100%
ZNTL
Nasdaq Manufacturing Chemicals
4,47 €
▲ 1,71 € (61,96%)
Cap. Boursière: 317,05 M
Prix
4,47 €
Cap. Boursière
317,05 M
Fourchette du Jour
2,86 € — 4,47 €
Fourchette 52 Semaines
1,06 € — 4,47 €
Volume
11 003 944
Ouverture 3,02 €
Moyenne 50J / 200J
2,52 €
77,08% above
Moyenne 50J / 200J
1,82 €
145,11% above

Quick Summary

Points Clés

Negative free cash flow of -125,25 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-51,98%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-40,05%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio7,76
Interest CoverageN/A

Valorisation

PE (TTM)
-2,31
En dessous de la moyenne du secteur (-1,47)
P/B Ratio1,25
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,3 -1,5
P/B 1,3 1,6
ROE % -52,0 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRSIX BRSIX
0,25% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,07% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -137,06 M
ROE -51,98% ROA -40,37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -125,25 M
ROIC -40,05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7,76
Interest Coverage N/A Asset Turnover 0,00
Working Capital 251,13 M Tangible Book Value 252,87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,31 Forward P/E N/A
P/B Ratio 1,25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -39,50%
Market Cap 317,05 M Enterprise Value 277,98 M
Per Share
EPS (Diluted TTM) -1,91 Revenue / Share 0,00
FCF / Share -1,77 OCF / Share -1,77
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 91,38%
SBC-Adj. FCF -153,21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 67,43 M — — —
Net Income -137,06 M -165,84 M -292,19 M -236,81 M -158,73 M
EPS (Diluted) -1,91 -2,33 -4,47 -4,48 0,00
Gross Profit — — — — —
Operating Income -152,81 M -191,19 M -299,51 M -227,29 M -216,54 M
EBITDA — — — — —
R&D Expenses 107,30 M 167,77 M 189,59 M 172,73 M 175,60 M
SG&A Expenses — — — — —
D&A 739 000,0 1,29 M 1,39 M 1,43 M 544 000,0
Interest Expense — — — — —
Income Tax 442 000,0 177 000,0 -601 000,0 -469 000,0 -297 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 288,97 M 430,34 M 551,69 M 539,31 M 454,51 M
Total Liabilities 72,76 M 93,15 M 114,30 M 105,29 M 90,03 M
Shareholders' Equity 216,20 M 337,19 M 437,28 M 434,02 M 364,48 M
Total Debt — — — — —
Cash & Equivalents 36,00 M 33,90 M 28,04 M 43,07 M 59,71 M
Current Assets 253,19 M 386,07 M 496,72 M 451,93 M 350,77 M
Current Liabilities 36,56 M 52,73 M 69,37 M 56,65 M 43,94 M